UCLA Ecological Medicine & Psychedelic Studies Initiative

Research

Key Investigators

Conor Murray, PhD
Ziva Cooper, PhD
Daniel Morberg, MD

Key Investigators

Anya Bershad, MD
Stephen Marder, MD
Michael Green, PhD

Key Investigators

Conor Murray, PhD
James Fadiman
Daniel Morberg, MD

Key Investigators

Charles Grob, MD
Ziva Cooper, PhD
Katrina DeBonis, MD

Key Investigators

Stephen Marder, MD
Kate Wolitzky-Taylor, PhD

Learn More

https://www.clinicaltrials.gov/study/NCT05790239

Key Investigators

Charles Grob, MD
Michael Makhinson, MD, PhD

Contact

email@contact.com

Learn More

https://www.clinicaltrials.gov/study/NCT05403086
https://psilocybin.lundquist.org/

Key Investigators

Conor Murray, PhD
Ziva Cooper, PhD
Charles Grob, MD
Edythe London, PhD
Marc Cohen, MD

Key Investigators

Jessica Jeffrey, MD, MPH, MBA
Marc Weintraub, PhD
David Miklowitz, PhD

Contact

Anabel Salimian (asalimian@mednet.ucla.edu)

Learn More

https://www.semel.ucla.edu/psychadelic-assisted-therapy/research

Key Investigators

David Krantz, MD, PhD
Jonathan Flint, MD
Anne Andrews, PhD

Key Investigators

David Krantz, MD, PhD
Jonathan Flint, MD
Anne Andrews, PhD

Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC)

This multicenter, triple-blind, phase 2, randomized controlled trial will evaluate the efficacy and safety of psilocybin therapy compared to an active control in treating demoralization in adults near the end of life (≤2 years life expectancy).